Stay updated on Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Sign up to get notified when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.

Latest updates to the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page
- Check2 days agoChange DetectedNew revision entry v3.3.4 was added to the record history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe history shows a new site revision label 'Revision: v3.3.3' was added and 'HHS Vulnerability Disclosure' as well as 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedThe Study Record Versions section shows an added 'Revision: v3.3.2' entry and removal of the 'Revision: v3.2.0' entry. These are minor release-note updates to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding lapse notice banner was removed from the page.SummaryDifference0.7%

- Check74 days agoChange DetectedVersion 10 (2025-04-16) adds updates to Recruitment Status, Study Status, Study Design, and Contacts/Locations in the Study Record.SummaryDifference0.1%

- Check102 days agoChange DetectedUpdated release notes: version bumped to v3.2.0 and added a government-status notice; previous v3.1.0 reference removed.SummaryDifference12%

Stay in the know with updates to Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.